Medicated Oils and G6PD Deficiency: Safety Guide

G6PD deficiency is one of the world’s most common genetic disorders, affecting an estimated 400 million people globally. In certain populations — particularly across Southeast Asia, sub-Saharan Africa, and parts of the Mediterranean — prevalence can run as high as 10–15% among males. Yet awareness of how everyday products like medicated oils can trigger a dangerous reaction in G6PD-deficient individuals remains surprisingly low.

This guide explains what G6PD deficiency is, which ingredients in popular medicated oils pose a risk, safer alternatives, and what signs of a reaction to watch for.

What Is G6PD Deficiency?

G6PD (Glucose-6-Phosphate Dehydrogenase) is an enzyme present in red blood cells. Its job is to protect those cells from oxidative damage — essentially acting as an antioxidant shield at the cellular level. In people with G6PD deficiency, a genetic mutation (inherited in an X-linked pattern) reduces or eliminates this enzyme’s activity.

When a G6PD-deficient person encounters a triggering substance — certain foods, drugs, or chemicals — the unprotected red blood cells come under oxidative stress and begin to break down (lyse). This process, called haemolytic anaemia, can range from mild (tiredness, mild jaundice) to life-threatening (severe anaemia requiring blood transfusion, organ stress).

Who Is Affected?

G6PD deficiency follows an X-linked recessive inheritance pattern, meaning:

Prevalence by population group (approximate):

Population Estimated Prevalence in Males
Hong Kong Chinese ~4%
Mainland Chinese (southern provinces) 3–8%
Filipino 12–15%
Thai 10–15%
Malay 3–7%
West African 10–25%
Mediterranean (Greek, Sardinian) 5–30% (varies by region)
Northern European <1%

Because the condition is most common in tropical and subtropical regions where malaria has historically been endemic (G6PD deficiency actually confers some malaria resistance), Asian and African communities — including large diaspora populations in the UK, USA, Canada, and Australia — have meaningfully higher rates than the general population of those countries.

Which Medicated Oil Ingredients Are Dangerous?

High Risk

Camphor (樟腦) Camphor is the highest-risk ingredient commonly found in medicated oils. It is a well-documented oxidative stressor for G6PD-deficient red blood cells. Multiple published case reports document haemolytic crises in G6PD-deficient infants and adults following topical camphor exposure — including through skin absorption.

Found in: Tiger Balm (both red and white formulas), Double Prawn Medicated Oil (雙飛人藥水), many traditional Chinese liniments, and some moth-repellent products placed near clothing.

Avoid entirely for G6PD-deficient individuals, especially infants.

Moderate Risk

Menthol (薄荷腦) Menthol’s oxidative risk is lower than camphor but is not negligible, particularly at high concentrations or with prolonged/extensive skin application. Menthol is found in White Flower Oil, most cooling oils, many throat lozenges, and topical pain relief gels.

Low-dose, short-duration topical use may be acceptable for adult G6PD patients, but this should be discussed with a doctor. Avoid extensive body coverage.

Methyl Salicylate (Wintergreen Oil / 冬青油) Methyl salicylate is metabolised to salicylate, which has mild oxidative properties. Risk is considered lower than camphor or menthol, but the same cautions apply: avoid large-area application and consult a doctor if uncertain.

Found in: White Flower Oil, many sports liniments, some traditional liniment formulas.

Lower Risk

Lavender Oil, Eucalyptus Oil (in moderate concentrations), Ginger Oil These essential oils do not have established G6PD-triggering activity at the concentrations used in most commercial products. However, as pure essential oils, very high concentrations should still be used cautiously. Always check the full ingredient list — “lavender” or “eucalyptus” products can still contain camphor or menthol as secondary ingredients.

Safe Alternatives for G6PD Patients

When seeking relief from common complaints, G6PD-deficient individuals can consider:

Always consult a pharmacist or doctor before using any new product if you or a family member has confirmed G6PD deficiency.

Signs of a Haemolytic Reaction

If a G6PD-deficient person has been exposed to a triggering substance — whether through a medicated oil, food (such as fava beans), or medication — watch for these symptoms, which typically appear within 24–72 hours:

Seek emergency medical care immediately if these symptoms appear. Haemolytic anaemia can escalate quickly, particularly in young children.

Practical Steps for G6PD Patients and Caregivers

  1. Confirm the diagnosis. G6PD deficiency is confirmed by a blood enzyme activity test. Many countries screen newborns routinely (Hong Kong public hospitals do; the UK NHS screens in high-risk groups).
  2. Carry a record. Keep a note in your wallet or phone health app stating the diagnosis, and list it with any doctor or pharmacist you consult.
  3. Read labels carefully. Look for camphor, menthol (or peppermint oil), and methyl salicylate (or wintergreen oil) on the ingredient list of any topical product.
  4. Check the medicine cabinet at home. Remove or quarantine camphor-containing products if a G6PD-deficient infant is in the household.
  5. Alert caregivers and schools. If a child has G6PD deficiency, inform teachers, grandparents, and other caregivers so they don’t inadvertently apply traditional remedies that contain camphor.
  6. Travel preparation. In some countries, traditional remedies containing camphor may be offered freely. Politely declining and explaining the allergy/deficiency is entirely appropriate.

This article is for general informational purposes and does not replace personalised medical advice. If you have G6PD deficiency or care for someone who does, consult your doctor or pharmacist before using any new topical product.